Łódź, 9 May 2022 – Janusz Wojciechowski, EU Commissioner for Agriculture, visited Proteon Pharmaceuticals today. Commissioner Wojciechowski’s visit to Proteon Pharmaceuticals is to get better acquainted

Proteon Pharmaceuticals today announced an investment of 21 million Euro to accelerate commercialization of its products, which aim to reduce the reliance on antibiotics within

PROTEON CONTINUES DIALOGUE WITH EU COMMISSION TO SECURE EARLY AUTHORIZATION In its first-ever evaluation of a bacteriophage feed additive, EFSA (European Food Safety Authority) concluded

The partnership will bring the emerging bacteriophage technology to poultry producers to help mitigate antimicrobial resistance. Warsaw, September 9, 2020 – Proteon Pharmaceuticals, a Polish

In 2008, a superbug caught from a New Delhi hospital claimed the life of a Swedish patient. British scientists who found this “superbug” in New

In response to the fight against coronavirus, Proteon Pharmaceuticals has joined the effort to create a new SARS-CoV-2 Coronavirus Detection Center in Lodz, Poland to

A Łódź pharmaceutical company has received over 2 million Euros to reduce animal antibiotics in the human food chain. In an attempt to find a

Proteon Pharamceuticals, a global leader in the development and commercialization of bacteriophages for industrial use in poultry farming, is now a member of the U.S.

Polish biotech company Proteon Pharmaceuticals S.A, a global leader in the development and commercialization of bacteriophages for industrial use in livestock farming in poultry, dairy

Proteon received the Best “Innovation in Aquaculture Award”, from His Excellency, Saeed Albahri Salem Alameri, and Hans van der Beek, Director General of the Abu

Proteon Founder and Board Member, Professor Jarosław Dastych, made a major presentation at the Bacteriophage Therapy Summit in Boston, USA. He spoke on the topic

Proteon Receives “2019 Animal Health Innovation Award” at the Animal Health Investment Europe Conference in London, UK.. COO and Board Member Matthew Tebeau accepted the

Proteon Pharmaceuticals COO Matthew Tebeau sat down with Christine Corrado from Proactive Investors at the 11th Annual BioTech Showcase in San Francisco. The Poland-based biotech

Proteon Pharmaceuticals today announced an investment of 21 million Euro to accelerate commercialization of its products, which aim to reduce the reliance on antibiotics within

Proteon Pharmaceuticals was an invited speaker at the 9th edition of the FIAAP Animal Nutrition conference held on March 27, 2018 in Bangkok, Thailand. This

Proteon Pharmaceuticals S.A., a Polish biotechnology firm has signed an agreement with an international Investment Fund, the Aqua-Spark fund, which invests in sustainable aquaculture. Proteon

Proteon Pharmaceuticals presents its unique product BAFADOR® at the international bacteriophage conference in Tbilisi Proteon Pharmaceuticals participated in the international conference “Centennial Celebration of Bacteriophage

In 2016 Proteon Pharmaceuticals awarded grants from Polish Center for Research & Development for Euro 3.2 m In 2016, Proteon Pharmaceuticals signed the agreements for